Table 2. Distribution of SLC5A8 methylation by tumor stage
|
Tumor stage |
SLC5A8 methylated |
SLC5A8 unmethylated |
|
Adenoma |
17 (24%) |
12 (23%) |
|
Dukes’ B |
24 (34%) |
16 (30%) |
|
Dukes’ C |
15 (21%) |
13 (25%) |
|
Dukes’ D |
6 (8%) |
5 (9%) |
|
Metastatic lesion |
7 (10%) |
7 (13%) |
Shown are numbers (and %) of colon neoplasms (tumor and cell lines) in each category defined by clinical stage and SLC5A8 methylation status.